Rifamycin Sodium
Preliminary reference disclaimer
This preliminary safety reference is generated from structured MolGraph catalog fields and public reference-style data. It is not a supplier-issued Safety Data Sheet and should not be used as a substitute for supplier-issued documentation, workplace safety review, transport classification, or regulatory compliance decisions. For supplier SDS or COA, submit a documentation request through MolGraph.
Preliminary safety reference
Available
Supplier-issued SDS
Available by request
COA
Available by RFQ / lot confirmation
Transport classification
Requires shipment review
CAS Number
14897-39-3
Chemical name
Rifamycin Sodium
Molecular formula
C37H46NNaO12
Molecular weight
719.7 g/mol
Synonyms
Rifamycin SV sodium; Rifamastene; Rifamycinum natricum; RIFAMYCIN SODIUM (MART.); RIFAMYCIN SODIUM [MART.]; RIFAMYCIN SODIUM (EP MONOGRAPH); RIFAMYCIN SODIUM [EP MONOGRAPH]; 2,7-(EPOXYPENTADECA(1,11,13)TRIENIMINO)NAPHTHO(2,1-B)FURAN-1,11(2H)-DIONE, 5,6,9,17,19,21-HEXAHYDROXY-23-METHOXY-2,4,12,16,18,20,22-HEPTAMETHYL-, 21-ACETATE, SODIUM SALT; Otofa; Rifamycin SV sodium salt; Rifamycin sodium [USAN]; Rifamyzin-Natrium
InChIKey
YVOFSHPIJOYKSH-NLYBMVFSSA-M
PubChem CID
23702994
Signal word
Warning
Catalog reference cue; confirm supplier documentation before use.
Hazard statements
H302
Catalog reference cue; confirm supplier documentation before use.
Physical property reference values are not available in the current MolGraph catalog record.
Shipment review
Shipment details require review before fulfillment.
Transport classification must be confirmed using supplier SDS and shipment documentation before dispatch.